Nobleza, Caren G.

HRN: 28-61-99  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2026
CO-AMOXICLAV 625MG (TAB)
03/25/2026
04/01/2026
PO
1 Tab
BID
UTI
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: